Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE2 SYNE1 SUN1	1.26e-05	5	218	3	GO:0140444
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DNAH3 DNAH2 DNAH17	3.75e-05	18	218	4	GO:0008569
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA3 SETX MYO5C SHOC1 ABCD2 DNAH5 DHX16 DNAH3 EP400 DDX52 ABCB5 DNAH2 ABCF2 ATP10A DICER1 MMAA IGHMBP2 DNAH17 AACS	4.69e-05	614	218	19	GO:0140657
GeneOntologyMolecularFunction	glucosamine-6-phosphate deaminase activity	GNPDA2 GNPDA1	1.19e-04	2	218	2	GO:0004342
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH5 DNAH3 DNAH2 DNAH17	2.30e-04	28	218	4	GO:0051959
GeneOntologyMolecularFunction	protein kinase activity	TRPM6 DCAF1 ABL2 PDPK1 TYRO3 GRK2 PIK3CG FGFR3 PAK5 NEK7 ZAP70 PRKAA2 PRKCH LTK PSKH2 TOP1 MAP3K2	3.34e-04	600	218	17	GO:0004672
GeneOntologyMolecularFunction	calcium ion binding	CAPN12 ADGRV1 ZZEF1 TBC1D8B RYR1 RYR2 NRXN1 NECAB1 FBLN7 CLXN S100A7L2 ANXA4 ITSN1 DUOX2 PLCD4 MYL12A EFHC2 MEGF8 AGRN	5.89e-04	749	218	19	GO:0005509
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH5 DNAH3 DNAH2 DNAH17	6.88e-04	37	218	4	GO:0045505
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	7.02e-04	4	218	2	GO:0005219
GeneOntologyMolecularFunction	phenylalanine-tRNA ligase activity	FARSA FARS2	7.02e-04	4	218	2	GO:0004826
GeneOntologyMolecularFunction	kinase activity	TRPM6 DCAF1 ABL2 PDPK1 NME9 TYRO3 GRK2 PIK3CG PIP5K1B FGFR3 PAK5 NEK7 ZAP70 PRKAA2 PRKCH LTK PSKH2 TOP1 MAP3K2	7.47e-04	764	218	19	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	TRPM6 DCAF1 ABL2 PDPK1 TYRO3 GRK2 PIK3CG PIP5K1B FGFR3 PAK5 NEK7 ZAP70 PRKAA2 PRKCH LTK PSKH2 TOP1 MAP3K2	8.13e-04	709	218	18	GO:0016773
GeneOntologyBiologicalProcess	negative regulation of programmed cell death	SYCP2L SETX ABL2 ASIC2 PDPK1 TYRO3 NAA35 GRK2 PIK3CG GLP1R NR1H4 CARD14 NGB PRAMEF19 SYNE1 ANXA4 ITSN1 PAK5 PRAMEF18 TEX11 CBS BBS10 PRKAA2 PRKCH LTK ARHGEF2 ENO1 DNAJC3 IL7	1.46e-05	1171	216	29	GO:0043069
GeneOntologyBiologicalProcess	negative regulation of apoptotic process	SETX ABL2 ASIC2 PDPK1 TYRO3 NAA35 GRK2 PIK3CG GLP1R NR1H4 CARD14 NGB PRAMEF19 SYNE1 ANXA4 ITSN1 PAK5 PRAMEF18 TEX11 CBS BBS10 PRKAA2 PRKCH LTK ARHGEF2 ENO1 DNAJC3 IL7	2.17e-05	1133	216	28	GO:0043066
GeneOntologyBiologicalProcess	glucosamine metabolic process	GNPDA2 GNPDA1 OGT	2.21e-05	6	216	3	GO:0006041
GeneOntologyBiologicalProcess	peptidyl-amino acid modification	ADCY10 ABL2 PDPK1 ZZEF1 NAA35 GRK2 NRXN1 NKTR FGFR3 TPST2 OGT NDUFAF5 RGPD8 NEK7 NSD1 CREBBP ZAP70 IL22 PRKAA2 PRKCH LTK ARHGEF2 AGRN TOP1 IL7	3.46e-05	976	216	25	GO:0018193
GeneOntologyCellularComponent	sarcomere	ABRA SPTBN1 MYOZ2 RYR1 RYR2 ANKRD2 SYNE2 ANK3 SYNE1 MYL12A ENO1	6.46e-05	249	218	11	GO:0030017
GeneOntologyCellularComponent	axonemal dynein complex	DNAH5 DNAH3 DNAH2 DNAH17	1.23e-04	25	218	4	GO:0005858
GeneOntologyCellularComponent	myofibril	ABRA SPTBN1 MYOZ2 RYR1 RYR2 ANKRD2 SYNE2 ANK3 SYNE1 MYL12A ENO1	1.46e-04	273	218	11	GO:0030016
GeneOntologyCellularComponent	nuclear membrane protein complex	SYNE2 SYNE1 SUN1	1.74e-04	11	218	3	GO:0106083
GeneOntologyCellularComponent	nuclear membrane microtubule tethering complex	SYNE2 SYNE1 SUN1	1.74e-04	11	218	3	GO:0106094
GeneOntologyCellularComponent	microtubule organizing center attachment site	SYNE2 SYNE1 SUN1	1.74e-04	11	218	3	GO:0034992
GeneOntologyCellularComponent	meiotic nuclear membrane microtubule tethering complex	SYNE2 SYNE1 SUN1	1.74e-04	11	218	3	GO:0034993
GeneOntologyCellularComponent	contractile muscle fiber	ABRA SPTBN1 MYOZ2 RYR1 RYR2 ANKRD2 SYNE2 ANK3 SYNE1 MYL12A ENO1	2.46e-04	290	218	11	GO:0043292
GeneOntologyCellularComponent	axoneme	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2 RP1L1 DNAH17	3.36e-04	207	218	9	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2 RP1L1 DNAH17	3.48e-04	208	218	9	GO:0097014
GeneOntologyCellularComponent	cilium	ADCY10 PDE1A CFAP251 ADGRV1 PGAM1 GRK2 DNAH5 TNPO1 CACNA1F DNAH3 CLXN PRAMEF19 DNAH2 CFAP210 PRAMEF18 CFAP298 BBS10 EFHC2 CEP250 RP1L1 DNAH17	4.85e-04	898	218	21	GO:0005929
MousePheno	abnormal circulating total protein level	SPTBN1 GC PCNX2 NRXN1 DNAH5 ITSN1 SUN1 DUOX2 SLCO1B1 MYL12A MMAA MIGA2 LTK ARHGEF2	3.95e-06	269	166	14	MP:0011888
Domain	EF-hand-dom_pair	CAPN12 CFAP251 ZZEF1 TBC1D8B RYR1 RYR2 NECAB1 CACNA1F CLXN S100A7L2 ITSN1 DUOX2 PLCD4 MYL12A EFHC2	1.33e-06	287	216	15	IPR011992
Domain	EF_hand_dom	CAPN12 ZZEF1 TBC1D8B RYR1 RYR2 NECAB1 CLXN S100A7L2 ITSN1 DUOX2 PLCD4 MYL12A EFHC2	3.21e-06	232	216	13	IPR002048
Domain	-	CAPN12 CFAP251 ZZEF1 TBC1D8B RYR1 RYR2 NECAB1 CLXN ITSN1 DUOX2 PLCD4 MYL12A EFHC2	1.15e-05	261	216	13	1.10.238.10
Domain	EF_HAND_2	CAPN12 ZZEF1 TBC1D8B RYR2 NECAB1 CLXN S100A7L2 ITSN1 DUOX2 PLCD4 MYL12A EFHC2	1.65e-05	231	216	12	PS50222
Domain	AAA	ABCA3 ABCD2 DNAH5 DNAH3 ABCB5 DNAH2 ABCF2 MMAA IGHMBP2	4.62e-05	144	216	9	SM00382
Domain	AAA+_ATPase	ABCA3 ABCD2 DNAH5 DNAH3 ABCB5 DNAH2 ABCF2 MMAA IGHMBP2	4.62e-05	144	216	9	IPR003593
Domain	Glucosamine6P_isomerase_CS	GNPDA2 GNPDA1	1.33e-04	2	216	2	IPR018321
Domain	Glucosamine6P_isomerase	GNPDA2 GNPDA1	1.33e-04	2	216	2	IPR004547
Domain	GLC_GALNAC_ISOMERASE	GNPDA2 GNPDA1	1.33e-04	2	216	2	PS01161
Domain	tRNA-synt_2d	FARSA FARS2	1.33e-04	2	216	2	PF01409
Domain	-	ADCY10 ABCA3 SETX SAMD9 DAP3 ABCD2 RAB29 DNAH5 CARD14 DHX16 TPST2 DNAH3 EP400 DDX52 ABCB5 DNAH2 ABCF2 DICER1 URGCP MMAA IGHMBP2	1.60e-04	746	216	21	3.40.50.300
Domain	P-loop_NTPase	ADCY10 ABCA3 SETX SAMD9 MYO5C DAP3 ABCD2 RAB29 DNAH5 CARD14 DHX16 TPST2 DNAH3 EP400 DDX52 ABCB5 DNAH2 ABCF2 DICER1 URGCP MMAA IGHMBP2	3.49e-04	848	216	22	IPR027417
Domain	Phenylalanyl-tRNA_Synthase	FARSA FARS2	3.96e-04	3	216	2	IPR002319
Domain	Ryanodine_rcpt	RYR1 RYR2	3.96e-04	3	216	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	3.96e-04	3	216	2	IPR009460
Domain	RyR	RYR1 RYR2	3.96e-04	3	216	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	3.96e-04	3	216	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	3.96e-04	3	216	2	IPR013333
Domain	Protein_kinase_ATP_BS	ABL2 PDPK1 TYRO3 GRK2 FGFR3 PAK5 NEK7 ZAP70 PRKAA2 PRKCH LTK PSKH2 MAP3K2	4.91e-04	379	216	13	IPR017441
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	IPR013602
Domain	DHC_N2	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	IPR011704
Domain	MT	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	PF12777
Domain	AAA_8	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	PF12780
Domain	AAA_5	DNAH5 DNAH3 DNAH2	5.05e-04	14	216	3	PF07728
Domain	EFh	ZZEF1 RYR2 NECAB1 CLXN ITSN1 DUOX2 PLCD4 MYL12A	5.13e-04	158	216	8	SM00054
Domain	DHC_fam	DNAH5 DNAH3 DNAH2	6.26e-04	15	216	3	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH3 DNAH2	6.26e-04	15	216	3	PF03028
Domain	Dynein_heavy_dom	DNAH5 DNAH3 DNAH2	6.26e-04	15	216	3	IPR004273
Domain	EF_HAND_1	CAPN12 TBC1D8B NECAB1 CLXN S100A7L2 ITSN1 DUOX2 PLCD4 MYL12A	6.32e-04	204	216	9	PS00018
Domain	C2_dom	CPNE8 FER1L6 PIK3CG ITSN1 PLCD4 SYTL5 PRKCH TNS1	6.56e-04	164	216	8	IPR000008
Domain	KASH	SYNE2 SYNE1	7.87e-04	4	216	2	IPR012315
Domain	KASH	SYNE2 SYNE1	7.87e-04	4	216	2	PS51049
Domain	KASH	SYNE2 SYNE1	7.87e-04	4	216	2	SM01249
Domain	KASH	SYNE2 SYNE1	7.87e-04	4	216	2	PF10541
Domain	Glc/Gal-6P_isomerase	GNPDA2 GNPDA1	7.87e-04	4	216	2	IPR006148
Domain	Glucosamine_iso	GNPDA2 GNPDA1	7.87e-04	4	216	2	PF01182
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SPTBN1 NOL6 NCBP1 FAM98B PGAM1 RYR2 FER1L6 DAP3 PXDN MIA2 NRXN1 SYNE2 RGPD5 RGPD8 COPA DDX52 SYNE1 ABCB5 ITSN1 DNAH2 DUOX2 ABCF2 CFAP210 SLC4A3 GSTK1 SEC23IP OGDHL ARHGEF2 ENO1 DNAJC3 TOP1 STAG2 DOP1A	2.19e-10	1442	222	33	35575683
Pubmed	A human MAP kinase interactome.	SETX ABL2 SPTBN1 SREBF2 ARHGEF11 NKTR ANK3 SYNE1 ITSN1 PAK5 LAMA3 CREBBP CEP250 ANKRD17 PRKCH TNS1 MAP3K2	1.88e-08	486	222	17	20936779
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL2 SPTBN1 GRK2 PXDN KCNJ4 SHOC1 FGFR3 DNAH5 COPA ITSN1 NSD1 LARS2 CREBBP ARHGEF2	3.56e-08	332	222	14	37433992
Pubmed	The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope.	SYNE2 SYNE1 SUN1	2.57e-07	3	222	3	16079285
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYCBP2 SPTBN1 ARHGEF11 FARSA NRXN1 KCNJ4 SYNE2 AMPD2 OGT RGPD8 ANK3 FXR2 SYNE1 ITSN1 PAK5 NSD1 SEC23IP ANKRD17 ARHGEF2 ENO1 TNS1 AGRN	2.88e-07	963	222	22	28671696
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 SPTBN1 NOL6 NCBP1 PGAM1 DAP3 FARSA SCFD1 DNAH5 TMEM117 DHX16 TNPO1 COPA DDX52 SYNE1 DUOX2 ABCF2 CBS DICER1 MYL12A PAXBP1 PRKAA2 SEC23IP ZC3HAV1L ENO1 TOP1 STAG2	4.94e-07	1425	222	27	30948266
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 SETX SPTBN1 SREBF2 METTL17 TNPO1 AMPD2 OGT ANK3 PRAMEF19 DDX52 ITSN1 SUN1 NSD1 PRAMEF18 PAXBP1 ANKRD17 OGDHL TNS1 GEN1 HERC4 AGRN STAG2	5.50e-07	1084	222	23	11544199
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	CHST14 SREBF2 NAA35 FARSA PXDN SCFD1 TNPO1 AMPD2 COPA DDX52 SUN1 DNAH2 ABCF2 OSGEP CPT1A URGCP SEC23IP ANKRD17 ARHGEF2 DNAJC3 STAG2	8.04e-07	942	222	21	31073040
Pubmed	SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeleton.	SYNE2 SYNE1 SUN1	1.02e-06	4	222	3	16648470
Pubmed	Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture.	SYNE2 SYNE1 SUN1	1.02e-06	4	222	3	28716842
Pubmed	LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina.	SYNE2 SYNE1 SUN1	1.02e-06	4	222	3	23071752
Pubmed	Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.	SYNE2 SYNE1 SUN1	1.02e-06	4	222	3	20108321
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX SAMD9 NOL6 SREBF2 ZZEF1 GNPAT DHX16 OGT DICER1 URGCP AP5B1 AACS ANKRD17 TNFAIP2 ARHGEF2 AGRN RUBCN	1.13e-06	650	222	17	38777146
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH5 DNAH3 DNAH2 DNAH17	1.54e-06	14	222	4	9373155
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	SPTBN1 NCBP1 FAM98B ELAC2 DAP3 FARSA TNPO1 COPA ANXA4 SUN1 ABCF2 LARS2 CBS MYL12A ZC3HAV1L TOP1	2.13e-06	607	222	16	39147351
Pubmed	LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins.	SYNE2 SYNE1 SUN1	2.54e-06	5	222	3	22632968
Pubmed	Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffness.	SYNE2 SYNE1 SUN1	2.54e-06	5	222	3	18396275
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CPNE8 SETX SPTBN1 NOL6 NCBP1 FAM98B CWC25 TBC1D8B FARSA NKTR METTL17 DHX16 EP400 COPA FXR2 DDX52 ANXA4 DICER1 TMED4 MYL12A PAXBP1 ANKRD17 ARHGEF2 ENO1 TOP1	2.67e-06	1371	222	25	36244648
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	OMA1 MYCBP2 ZZEF1 ELAC2 DAP3 MIA2 SYNE2 SCFD1 RAB29 METTL17 NDUFAF5 RGPD8 COPA FXR2 SYNE1 SUN1 LARS2 MIGA2 GSTK1 SEC23IP OGDHL PRKCH ARHGEF2 GEN1 TOP1 CYB5A	3.95e-06	1496	222	26	32877691
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	DCAF1 RNGTT MYCBP2 CWC25 TUFT1 NRXN1 OSBPL1A NKTR TNPO1 CUL4A AMPD2 CNOT11 OGT ANK3 NEK7 OSGEP CREBBP CBS DICER1 URGCP TMED4 EFHC2 SEC23IP MAP3K2	4.56e-06	1321	222	24	27173435
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SPTBN1 NCBP1 FAM98B ELAC2 DAP3 FARSA MIA2 SYNE2 TRMT1L CUL4A AMPD2 CNOT11 OGT COPA FXR2 ABCF2 CPT1A CBS MYL12A PAXBP1 ZC3HAV1L ARHGEF2 ENO1 TOP1 STAG2	4.63e-06	1415	222	25	28515276
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 SPTBN1 NOL6 NCBP1 PGAM1 SYNE2 DHX16 TNPO1 COPA FXR2 DDX52 NSD1 DICER1 ANKRD17 TOP1 STAG2	5.37e-06	653	222	16	22586326
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH5 DNAH3 DNAH2	8.81e-06	7	222	3	9256245
Pubmed	The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.	DCAF1 CUL4A DICER1	8.81e-06	7	222	3	23849790
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH5 DNAH2 DNAH17	8.81e-06	7	222	3	31178125
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 ARHGEF11 ZZEF1 ELAC2 RYR1 PCNX2 SH3TC1 TPST2 EP400 RNPEPL1 NSD1 LARS2 MROH1 MEGF8 MTMR14 OGDHL LRRC14 TNFAIP2 LTK ARHGEF2 AGRN	9.52e-06	1105	222	21	35748872
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NOL6 RYR1 RYR2 FER1L6 DAP3 SYNE2 FXR2 DNAH2 CREBBP MEGF8 IL22 SEC23IP ANKRD17 ARHGEF2 STAG2	1.72e-05	638	222	15	31182584
Pubmed	Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle.	SYNE2 SYNE1 SUN1	2.98e-05	10	222	3	28533284
Pubmed	The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.	DCAF1 CUL4A CREBBP	2.98e-05	10	222	3	20347598
Pubmed	Nuclear membrane proteins with potential disease links found by subtractive proteomics.	SYNE2 SYNE1 SUN1	2.98e-05	10	222	3	12958361
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RNGTT MYCBP2 NOL6 NCBP1 FARSA TRMT1L METTL17 COPA FXR2 DDX52 ABCF2 URGCP IGHMBP2 OGDHL ARHGEF2 TOP1	3.38e-05	759	222	16	35915203
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CPNE8 MYCBP2 NOL6 NCBP1 MYO5C SYNE2 DHX16 TNPO1 EP400 COPA DDX52 SYNE1 SUN1 ABCF2 DICER1 ARHGEF2 ENO1 TOP1 STAG2	3.55e-05	1024	222	19	24711643
Pubmed	Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study.	GNPDA2 GNPDA1	4.06e-05	2	222	2	12965206
Pubmed	[Determination of the binding site of testis-specific nucleoporin BS-63 to transportin (karopherin beta 2) and the proof of their combination in vitro].	RGPD5 TNPO1	4.06e-05	2	222	2	12905863
Pubmed	Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling.	GRAPL GRAP	4.06e-05	2	222	2	19836472
Pubmed	Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin.	GNPDA2 GNPDA1	4.06e-05	2	222	2	12616532
Pubmed	Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.	SYNE2 SYNE1	4.06e-05	2	222	2	11792814
Pubmed	Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.	SYNE2 SYNE1	4.06e-05	2	222	2	24931616
Pubmed	Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels.	SREBF2 AACS	4.06e-05	2	222	2	22985732
Pubmed	Dynamic changes in DICER levels in adipose tissue control metabolic adaptations to exercise.	DICER1 PRKAA2	4.06e-05	2	222	2	32900951
Pubmed	Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction.	GRAPL GRAP	4.06e-05	2	222	2	11971956
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	4.06e-05	2	222	2	17259277
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	4.06e-05	2	222	2	14722100
Pubmed	Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1.	NR1H4 SLCO1B1	4.06e-05	2	222	2	20827719
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	4.06e-05	2	222	2	26009179
Pubmed	Transcriptional Control of Trpm6 by the Nuclear Receptor FXR.	TRPM6 NR1H4	4.06e-05	2	222	2	35216094
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	4.06e-05	2	222	2	32899693
Pubmed	Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damage.	PIK3CG TLR9	4.06e-05	2	222	2	31836766
Pubmed	Arg and DAP3 expression was correlated with human thymoma stage.	ABL2 DAP3	4.06e-05	2	222	2	15679048
Pubmed	Insights into Vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS).	CYP24A1 GC	4.06e-05	2	222	2	15225763
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	4.06e-05	2	222	2	15033925
Pubmed	Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds.	SYNE2 SYNE1	4.06e-05	2	222	2	22768332
Pubmed	Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjögren's syndrome.	GRAPL GRAP	4.06e-05	2	222	2	15174222
Pubmed	Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.	CYP24A1 GC	4.06e-05	2	222	2	23456391
Pubmed	GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo.	GRK2 GLP1R	4.06e-05	2	222	2	33658023
Pubmed	Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells.	SPTBN1 ANK3	4.06e-05	2	222	2	17074766
Pubmed	CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5.	LAMA3 CREBBP	4.06e-05	2	222	2	16219677
Pubmed	The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation.	NR1H4 TLR9	4.06e-05	2	222	2	23372731
Pubmed	Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation.	SYNE2 SYNE1	4.06e-05	2	222	2	17267447
Pubmed	Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis.	GRAPL GRAP	4.06e-05	2	222	2	37343720
Pubmed	Nesprins: tissue-specific expression of epsilon and other short isoforms.	SYNE2 SYNE1	4.06e-05	2	222	2	24718612
Pubmed	Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response.	SYNE2 SYNE1	4.06e-05	2	222	2	24586179
Pubmed	Construction of a global pain systems network highlights phospholipid signaling as a regulator of heat nociception.	PIK3CG PIP5K1B	4.06e-05	2	222	2	23236288
Pubmed	SHOC1 is a ERCC4-(HhH)2-like protein, integral to the formation of crossover recombination intermediates during mammalian meiosis.	SHOC1 TEX11	4.06e-05	2	222	2	29742103
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	4.06e-05	2	222	2	30542613
Pubmed	Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.	SYNE2 SYNE1	4.06e-05	2	222	2	17761684
Pubmed	Nesprin-1-alpha2 associates with kinesin at myotube outer nuclear membranes, but is restricted to neuromuscular junction nuclei in adult muscle.	SYNE2 SYNE1	4.06e-05	2	222	2	31578382
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	4.06e-05	2	222	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	4.06e-05	2	222	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	4.06e-05	2	222	2	11673462
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	4.06e-05	2	222	2	25370123
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	4.06e-05	2	222	2	18618700
Pubmed	A conserved KASH domain protein associates with telomeres, SUN1, and dynactin during mammalian meiosis.	SYNE2 SYNE1 SUN1	4.08e-05	11	222	3	22826121
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	NOL6 NCBP1 FAM98B DAP3 FARSA NKTR SCFD1 TRMT1L DHX16 CUL4A OGT EP400 COPA FXR2 DDX52 ABCF2 PAXBP1 GSTK1 ARHGEF2 ENO1 AGRN TOP1	4.19e-05	1318	222	22	30463901
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DCAF1 CPNE8 MYO5C PXDN COPA DICER1 ANKRD17 ARHGEF2	5.03e-05	202	222	8	33005030
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ABL2 ARHGEF11 RYR1 MIA2 KCNN1 NR1H4 TNPO1 CACNA1F TLR9 RPUSD2	5.58e-05	329	222	10	17474147
Pubmed	Defining the membrane proteome of NK cells.	MYCBP2 MARCHF6 PGAM1 FARSA GRK2 MIA2 PIK3CG GNPAT COPA FXR2 DDX52 ABCF2 CPT1A GSTK1 IGHMBP2 ANKRD17 ENO1 DNAJC3 STAG2 CYB5A	6.70e-05	1168	222	20	19946888
Pubmed	KASH protein Syne-2/Nesprin-2 and SUN proteins SUN1/2 mediate nuclear migration during mammalian retinal development.	SYNE2 SYNE1 SUN1	7.00e-05	13	222	3	21177258
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SETX MYCBP2 SPTBN1 NCBP1 LRCH1 DAP3 FARSA NRXN1 DHX16 TNPO1 OGT EP400 COPA SYNE1 MYL12A PAXBP1 ARHGEF2 AGRN TOP1	7.37e-05	1082	222	19	38697112
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYCBP2 DIS3L SPTBN1 NCBP1 MIA2 NECAB1 OSBPL1A KCNN1 OGT ANK3 COPA SYNE1 ITSN1 CFAP298 CREBBP CBS SLC4A3 TMED4 SEC23IP GEN1 TOP1	8.47e-05	1285	222	21	35914814
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SETX RNGTT NCBP1 ZZEF1 RYR1 IGSF10 DENND4B CACNA1F UBQLNL DNAH3 FXR2 ITSN1 DNAH2 BRME1 MYL12A	8.66e-05	736	222	15	29676528
Pubmed	SUN1/2 and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice.	SYNE2 SYNE1 SUN1	8.87e-05	14	222	3	19874786
Pubmed	MED12 regulates a transcriptional network of calcium-handling genes in the heart.	RYR1 RYR2 KCNN1	8.87e-05	14	222	3	28724790
Pubmed	Reverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiation.	SETX SPTBN1 NKTR MYL12A	9.05e-05	37	222	4	23180766
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ABRA MYCBP2 SPTBN1 MYOZ2 RYR1 SYNE2 SYNE1 ABCF2 OSGEP MTMR14 ENO1 STAG2	9.40e-05	497	222	12	23414517
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	SAMD9 MYCBP2 NAA35 ANK3 ANXA4 CPT1A DICER1 GSTK1 TNS1	1.07e-04	288	222	9	38496616
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF1 DIS3L PLCXD1 ZZEF1 DAP3 NAA35 SH3TC1 ANKRD2 ABHD8 CUL4A OGT EP400 FXR2 DDX52 CREBBP DICER1 ANKRD17 LTK TOP1	1.10e-04	1116	222	19	31753913
Pubmed	A long non-coding RNA specifically expressed in early embryos programs the metabolic balance in adult mice.	PGAM1 CPT1A PRKAA2 ENO1	1.12e-04	39	222	4	33059001
Pubmed	Integrative predictive model of coronary artery calcification in atherosclerosis.	SREBF2 ADORA2B NR1H4 AMPD2 ATG9B TLR9 CBS PRKAA2	1.21e-04	229	222	8	19948975
Pubmed	DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).	SETX IGHMBP2	1.21e-04	3	222	2	15106121
Pubmed	Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos.	SPTBN1 ANK3	1.21e-04	3	222	2	17620337
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2	1.21e-04	3	222	2	18403125
Pubmed	Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130.	IL10RB IL22	1.21e-04	3	222	2	32611765
Pubmed	Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions.	DCAF1 CUL4A	1.21e-04	3	222	2	20069611
Pubmed	Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.	IL10RB IL22	1.21e-04	3	222	2	15120653
Pubmed	Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.	ZAP70 PRKCH	1.21e-04	3	222	2	22664044
Pubmed	Upregulation of α enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.	CREBBP ENO1	1.21e-04	3	222	2	34547627
Pubmed	Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.	CUL4A DICER1	1.21e-04	3	222	2	26965998
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2	1.21e-04	3	222	2	7876312
Pubmed	Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells.	RYR1 RYR2	1.21e-04	3	222	2	24123915
GeneFamily	EF-hand domain containing	CAPN12 ZZEF1 TBC1D8B RYR2 NECAB1 CLXN S100A7L2 ITSN1 DUOX2 PLCD4 MYL12A EFHC2	3.39e-07	219	152	12	863
GeneFamily	Dyneins, axonemal	DNAH5 DNAH3 DNAH2 DNAH17	1.05e-05	17	152	4	536
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	2.09e-04	3	152	2	287
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE2 SYNE1	4.17e-04	4	152	2	1252
GeneFamily	SH2 domain containing	ABL2 GRAPL ZAP70 TNS1 GRAP	1.63e-03	101	152	5	741
Coexpression	GSE36009_WT_VS_NLRP10_KO_DC_DN	TBC1D8B ADORA2B PIK3CG OGT MTMR14 AP5B1 SEC23IP TNFAIP2 ARHGEF2 TOP1	7.30e-06	199	219	10	M8777
Coexpression	GSE24726_WT_VS_E2_2_KO_PDC_DN	DCAF1 ABCA3 NCBP1 FAM98B TPST2 SUN1 ABCF2 AACS DNAJC3 CYB5A	7.62e-06	200	219	10	M8061
ToppCell	PND01-03-samps-Epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 TUFT1 MYO5C PIP5K1B TSPAN11 ANK3 ANXA4 LAMA3	3.70e-07	185	220	9	2b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	CATIP CFAP251 NME9 DNAH5 DNAH3 ATG9B CLXN DNAH2 CFAP210	3.70e-07	185	220	9	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA3 PLCXD1 ADGRV1 NECAB1 PIP5K1B ANK3 HIF3A ARHGEF2 CYB5A	4.05e-07	187	220	9	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 TUFT1 MYO5C PIP5K1B TSPAN11 ANK3 ANXA4 LAMA3	4.05e-07	187	220	9	23fe3cdd6cc9b067086a8392d104186d300298ea
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 ADGRV1 MYO5C KCNQ3 PIP5K1B DNAH5 ANK3 LAMA3 CYB5A	4.24e-07	188	220	9	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCBP1 SYNE2 NKTR RGPD5 OGT SYNE1 ZAP70 MYL12A PRKCH	4.43e-07	189	220	9	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRTM3 ADGRV1 MYO5C NECAB1 FGFR3 ANK3 LAMA3 HIF3A ARHGEF2	4.63e-07	190	220	9	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 MYO5C NECAB1 ANKDD1B KCNQ3 PIP5K1B DNAH5 ANK3	5.06e-07	192	220	9	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 MYO5C KCNQ3 PIP5K1B DNAH5 ANK3 LAMA3 CYB5A	5.06e-07	192	220	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	CFAP251 SPTBN1 SYNE2 DNAH5 DNAH3 CLXN ANK3 SYNE1 CFAP210	5.76e-07	195	220	9	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	CFAP251 SPTBN1 SYNE2 DNAH5 DNAH3 CLXN ANK3 SYNE1 CFAP210	5.76e-07	195	220	9	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 ADGRV1 LRCH1 MYO5C SYNE2 DNAH5 CACNA1F LAMA3 OGDHL	6.27e-07	197	220	9	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	AADAC ABCA3 PLCXD1 ADGRV1 MYO5C ANK3 LAMA3 SYTL5 OGDHL	6.27e-07	197	220	9	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 ADGRV1 MYO5C SYNE2 CACNA1F ANK3 LAMA3 SYTL5 OGDHL	6.27e-07	197	220	9	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NME9 DNAH5 DNAH3 CLXN DNAH2 DUOX2 CFAP210 SLC9A4	1.07e-06	155	220	8	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 GC MYO5C PIP5K1B DNAH5 ANK3 LAMA3	1.07e-06	155	220	8	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NME9 DNAH5 DNAH3 CLXN DNAH2 DUOX2 CFAP210 SLC9A4	1.07e-06	155	220	8	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	15-Airway-Epithelial-Multiciliated_precursor\|Airway / Age, Tissue, Lineage and Cell class	CFAP251 MYO5C DNAH5 ATG9B CLXN CFAP210 EFHC2 DNAH17	3.01e-06	178	220	8	d8e0a696bdd6af6422d72af0413f9dbd6bc02afa
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADGRV1 TUFT1 FER1L6 MYO5C NKTR ANK3 SUN1 PRKAA2	3.14e-06	179	220	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ABCA3 ADGRV1 NECAB1 KCNQ3 PIP5K1B ANK3 SYNE1 CYB5A	3.27e-06	180	220	8	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ABRA MYOZ2 LRRTM3 RYR2 ANKRD2 ANK3 MYL12A PRKAA2	3.55e-06	182	220	8	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 NECAB1 KCNQ3 PIP5K1B ANK3 LAMA3 CYB5A	3.69e-06	183	220	8	6847c1252d6bb105524f812658112517fd351eab
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CATIP CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.00e-06	185	220	8	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP251 NME9 ANKDD1B DNAH5 DNAH3 DNAH2 CFAP210 EFHC2	4.00e-06	185	220	8	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CATIP CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.33e-06	187	220	8	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	droplet-Thymus-nan-18m-Myeloid-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AADAC MYO5C FGFR3 NR1H4 ANK3 CBS PRKAA2 AGRN	4.33e-06	187	220	8	ed69e7cbd6fb59363b0e26f24887fc49405397ce
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CYP24A1 ADGRV1 FER1L6 MYO5C FGFR3 DNAH5 ANK3 CYB5A	4.69e-06	189	220	8	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 ABCA3 TUFT1 MYO5C MIA2 TSPAN11 ANK3 TEX11	5.06e-06	191	220	8	c06bbad24e4897b2c3b5015e4de02411ebf75367
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 MYO5C NECAB1 PIP5K1B ANK3 LAMA3 CYB5A	5.06e-06	191	220	8	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	facs-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 ABCA3 TUFT1 MYO5C MIA2 TSPAN11 ANK3 TEX11	5.06e-06	191	220	8	5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 PIP5K1B ANK3 LAMA3 HIF3A ARHGEF2 CYB5A	5.26e-06	192	220	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 MYO5C NECAB1 KCNQ3 PIP5K1B DNAH5 ANK3	5.26e-06	192	220	8	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPM6 ABCA3 TUFT1 MYO5C ADORA2B PIP5K1B TSPAN11 ANK3	5.26e-06	192	220	8	4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ABCA3 ADGRV1 MYO5C NECAB1 KCNQ3 PIP5K1B ANK3 CYB5A	5.26e-06	192	220	8	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CFAP251 DNAH5 DNAH3 CLXN SYNE1 DNAH2 CFAP210 IL7	5.47e-06	193	220	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE2 NKTR OGT ANK3 SYNE1 TEX11 ZAP70 SLC9A4	5.47e-06	193	220	8	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 ADGRV1 MYO5C KCNQ3 PIP5K1B ANK3 SYNE1 LAMA3	5.68e-06	194	220	8	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP251 NME9 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	5.68e-06	194	220	8	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA3 PLCXD1 ADGRV1 NECAB1 PIP5K1B ANK3 SYNE1 LAMA3	5.68e-06	194	220	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP251 SHOC1 DNAH5 DNAH3 CLXN SYNE1 DNAH2 CFAP210	5.68e-06	194	220	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPTBN1 SYNE2 NKTR OGT ANK3 ZAP70 LRRN3 PRKCH	5.90e-06	195	220	8	4bdedd924564a260841a9153604026b57487c83d
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP251 DNAH5 DNAH3 CLXN SYNE1 DNAH2 CFAP210 EFHC2	5.90e-06	195	220	8	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 ADGRV1 MYO5C PIP5K1B DNAH5 ANK3 SYNE1 LAMA3	5.90e-06	195	220	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	CFAP251 SPTBN1 SYNE2 DNAH5 DNAH3 ANK3 SYNE1 CFAP210	6.12e-06	196	220	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	CFAP251 SPTBN1 SYNE2 DNAH5 DNAH3 ANK3 SYNE1 CFAP210	6.12e-06	196	220	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 PXDN SYNE2 GRAPL SYNE1 HIF3A PRKCH LTK	6.12e-06	196	220	8	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SPTBN1 PXDN SYNE2 GRAPL SYNE1 HIF3A PRKCH LTK	6.12e-06	196	220	8	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE2 NKTR OGT ANK3 SYNE1 TEX11 ZAP70 SLC9A4	6.35e-06	197	220	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE2 NKTR RGPD5 OGT ANK3 SYNE1 ZAP70 PRKCH	6.35e-06	197	220	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ADGRV1 MYO5C NECAB1 KCNQ3 PIP5K1B LAMA3 CYB5A	6.84e-06	199	220	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 SREBF2 ADGRV1 MYO5C PIP5K1B ANK3 LAMA3 CYB5A	6.84e-06	199	220	8	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SETX SYNE2 OSBPL1A DNAH5 ITSN1 MYL12A DNAJC3 STAG2	6.84e-06	199	220	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE2 NKTR RGPD5 OGT ANK3 SYNE1 ZAP70 PRKCH	6.84e-06	199	220	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ADGRV1 MYO5C NECAB1 KCNQ3 PIP5K1B ANK3 LAMA3	6.84e-06	199	220	8	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CATIP CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	7.10e-06	200	220	8	5abd6d81e1cc354484ae693fcd708d78926e75b5
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CATIP CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	7.10e-06	200	220	8	9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D8B ELAC2 FGFR3 ABCF2 BBS10 SLC35F4 PRKAA2	7.92e-06	145	220	7	186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CATIP NME9 DNAH5 DNAH3 CLXN DNAH2 CFAP210	1.17e-05	154	220	7	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CATIP NME9 DNAH5 DNAH3 CLXN DNAH2 CFAP210	1.17e-05	154	220	7	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 CYP24A1 NRXN1 ANK3 WDR87 PSKH2 CYB5A	1.33e-05	157	220	7	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABRA SPTBN1 BCHE GRAPL NIPAL4 PRKCH GRAP	1.63e-05	162	220	7	5428c9fdb816f564395ebb4520448e5f3a42b025
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NME9 DNAH5 DNAH3 CLXN DNAH2 DUOX2 SLC9A4	1.76e-05	164	220	7	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	SERPINE3 ABCD2 FBLN7 ANK3 HIF3A FREM3 LRRN3	1.98e-05	167	220	7	78d264af390bd89942ffbb2991dc94f50756d4c9
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 NME9 SYNE2 TPST2 SYNE1 LRRN3 PRKCH	2.06e-05	168	220	7	b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff
ToppCell	Control\|World / group, cell type (main and fine annotations)	ABCA3 ADGRV1 MYO5C PIP5K1B ANK3 SYNE1 LAMA3	2.06e-05	168	220	7	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FER1L6 SH3TC1 SHOC1 TMEM117 ANXA4 LAMA3 PSKH2	2.14e-05	169	220	7	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	AADAC PXDN SHOC1 KCNQ3 LAMA3 SYTL5 AGRN	2.40e-05	172	220	7	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BCHE FER1L6 FIBIN GLP1R LAMA3 IL7	2.67e-05	118	220	6	3f0a304ef9c9e5ba047fc09f4372590eed624328
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABRA MYOZ2 LRRTM3 RYR2 ANKRD2 MYL12A PRKAA2	2.78e-05	176	220	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AADAC PDE1A ADGRV1 FGFR3 ANK3 HIF3A CYB5A	3.09e-05	179	220	7	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 ABCA3 ADGRV1 MYO5C SYNE2 ANK3 LAMA3	3.09e-05	179	220	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	ADGRV1 KCNQ3 DNAH5 TSPAN11 ANK3 TOP1 CYB5A	3.32e-05	181	220	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	3.44e-05	182	220	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	CV-Severe-4\|CV / Virus stimulation, Condition and Cluster	PGAM1 PIP5K1B FBLN7 NIPAL4 CBS ZC3HAV1L ENO1	3.44e-05	182	220	7	c19bbc43d97c426aec37414f46f667a19b62a257
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 SPTBN1 ADGRV1 KCNQ3 ANK3 LAMA3 SLC35F4	3.56e-05	183	220	7	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 MYO5C ADORA2B PIP5K1B TSPAN11 ANK3	3.56e-05	183	220	7	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	PND07-28-samps-Epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 MYO5C ADORA2B PIP5K1B DNAH5 ANK3	3.56e-05	183	220	7	a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TRPM6 ABCA3 MYO5C ADORA2B PIP5K1B TSPAN11 ANK3	3.56e-05	183	220	7	23e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MYOZ2 LRRTM3 RYR2 ANKRD2 ANK3 MYL12A PRKAA2	3.69e-05	184	220	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 ADGRV1 MYO5C KCNQ3 PIP5K1B ANK3 CYB5A	3.69e-05	184	220	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	CAPN12 PDE1A ADGRV1 KCNQ3 DNAH5 ANK3 CYB5A	3.82e-05	185	220	7	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 ADGRV1 MYO5C PIP5K1B ANK3 LAMA3 PAXBP1	3.82e-05	185	220	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYOZ2 LRRTM3 RYR2 ANKRD2 ANK3 MYL12A PRKAA2	3.82e-05	185	220	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	3.82e-05	185	220	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFAP251 NME9 DNAH3 CLXN DNAH2 CFAP210 EFHC2	3.82e-05	185	220	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AADAC PDE1A ADGRV1 MYO5C DNAH5 ANK3 CYB5A	3.95e-05	186	220	7	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CATIP CFAP251 NME9 DNAH3 CLXN DNAH2 CFAP210	3.95e-05	186	220	7	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP251 NME9 DNAH5 DNAH3 CLXN DNAH2 CFAP210	3.95e-05	186	220	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCHE MYO5C FGFR3 LARS2 CBS TNS1 AGRN	4.09e-05	187	220	7	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 GLP1R SYNE2 TPST2 SYNE1 ZAP70 PRKCH	4.09e-05	187	220	7	0bca79cea4886b66350c56c61859bd71e1e7a85c
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP251 NME9 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.09e-05	187	220	7	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 ABCA3 MYO5C ADORA2B PIP5K1B TSPAN11 ANK3	4.23e-05	188	220	7	b1049003ca79c340bb8c78da66bdc0956e1aebc2
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 ABCA3 MYO5C ADORA2B PIP5K1B TSPAN11 ANK3	4.23e-05	188	220	7	3dd571bd8e7358b4346dea71f6bf9602dabf583c
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.23e-05	188	220	7	606907c865bd2f11bb6474932716550f7723d858
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ABCA3 ADGRV1 MYO5C PIP5K1B DNAH5 ANK3 LAMA3	4.23e-05	188	220	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.37e-05	189	220	7	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	CAPN12 ABCA3 SREBF2 KCNQ3 DNAH5 CPT1A MROH1	4.37e-05	189	220	7	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	CFAP251 DNAH5 DNAH3 CLXN DNAH2 CFAP210 EFHC2	4.37e-05	189	220	7	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	Ciliated\|World / shred by cell class for parenchyma	CATIP CFAP251 DNAH5 CLXN DNAH2 CFAP210 EFHC2	4.37e-05	189	220	7	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCD2 ANXA4 CPT1A ATP10A SLC9A4 TNFAIP2 TNS1	4.37e-05	189	220	7	287e59104687fe1665232c52993889f0f2c97f17
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A	DCAF1 AADAC RNGTT SPTBN1 PCNX2 SH3TC1 DNAH3 SYNE1 RNPEPL1 CPT1A CEP250 TNS1	4.16e-07	193	220	12	4488_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A	ABCA3 SPTBN1 TBC1D8B MIA2 MPPE1 OGT ABCF2 CPT1A CEP250 TNS1 AGRN	3.46e-06	196	220	11	6745_DN
Drug	diacetylene	ABRA ASIC2 SYNE1 CBS	7.87e-06	14	220	4	CID000009997
Drug	magnesium	TRPM6 SPTBN1 BCHE GC ADGRV1 RYR1 RYR2 MYO5C FARSA GRK2 KCNJ4 FGFR3 DNAH5 CARD14 TNPO1 DNAH3 AMPD2 DDX52 ABCB5 LAMA3 OSGEP DICER1 ZAP70 MYL12A FARS2 DNAH17 PRKCH ENO1 TOP1 CYB5A	1.26e-05	1325	220	30	CID000000888
Drug	oxotremorine-M	PLCXD1 BCHE KCNQ3 TNPO1 SYNE1 PLCD4 TNS1	1.36e-05	81	220	7	CID000004629
Drug	glucosaminitol	GC GNPDA2 GNPDA1 OGT	1.41e-05	16	220	4	CID000189022
Drug	monomethylarsonic acid	ABRA SETX TYRO3 TNPO1 OTP IGHMBP2	1.65e-05	56	220	6	CID000008947
Drug	5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	RNGTT PDPK1 NKTR FGFR3 FXR2 DDX52 ABCF2 DICER1 CEP250 RUBCN	1.94e-05	193	220	10	901_DN
Drug	lindane	RNGTT PLCXD1 RYR1 RYR2 FGFR3 CACNA1F PLCD4 CBS TNFAIP2	1.96e-05	154	220	9	CID000000727
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A	MARCHF6 ARHGEF11 GRK2 GLP1R PIP5K1B NKTR CPT1A MEGF8 CEP250 ZMYM6	2.12e-05	195	220	10	2478_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 10uM; PC3; HT_HG-U133A	ABCA3 RNGTT NR1H4 NDUFAF5 FXR2 ABCF2 CPT1A ATP10A SLC16A4 TNFAIP2	2.31e-05	197	220	10	7388_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; PC3; HT_HG-U133A	SETX RNGTT GRK2 KCNJ4 GLP1R NDUFAF5 RNPEPL1 ABCF2 IGHMBP2 PRKCH	2.31e-05	197	220	10	5860_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DCAF1 ABL2 SPTBN1 RYR1 MIA2 ITSN1 SUN1 KCTD17 FARS2 IL22	2.41e-05	198	220	10	1529_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	SAMD9 RNGTT SPTBN1 SH3TC1 DNAH3 SYNE1 KCTD17 PRKAA2 OGDHL TNS1	2.41e-05	198	220	10	3711_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DCAF1 SREBF2 LRCH1 RYR2 PCNX2 ITSN1 SUN1 NSD1 CEP250 HERC4	2.41e-05	198	220	10	2217_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; HL60; HT_HG-U133A	RNGTT NCBP1 GRK2 OSBPL1A CPT1A URGCP BBS10 LRRC14 AGRN ZMYM6	2.41e-05	198	220	10	1849_DN
Drug	verapamil	ADCY10 ABRA ABCA3 CYP24A1 RYR1 RYR2 KCNJ4 KCNN1 KCNQ3 ABCD2 CACNA1F ABCB5 ABCF2 SLCO1B1 SEC23IP PRKCH	2.45e-05	490	220	16	CID000002520
Drug	Repaglinide [135062-02-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	CWC25 PCNX2 TPST2 EP400 COPA FXR2 DDX52 FARS2 LRRC14 DNAJC3	2.63e-05	200	220	10	5862_DN
Drug	diphenylmethane	CYP24A1 GC NR1H4 SYNE1	2.93e-05	19	220	4	CID000007580
Drug	FA 5	FARSA LARS2 CBS FARS2	3.64e-05	20	220	4	CID000193730
Drug	CHEMBL2115063	ADORA2B GNPDA2 TNPO1 GNPDA1 TNS1	4.02e-05	40	220	5	CID009876936
Drug	carbachol	ADCY10 PDE1A PLCXD1 BCHE RYR1 RYR2 MYO5C ADORA2B GRK2 PIK3CG KCNJ4 KCNN1 CARD14 CACNA1F LAMA3 PLCD4 MYL12A SEC23IP PRKCH	4.27e-05	688	220	19	CID000002551
Disease	Statin causing adverse effect in therapeutic use	RYR1 SLCO1B1	5.04e-05	2	210	2	cv:C0570410
Disease	Statin-induced myopathy	RYR1 SLCO1B1	5.04e-05	2	210	2	cv:CN181199
Disease	survival time, Sepsis	SAMD9 FIBIN SLC35F4	7.46e-05	12	210	3	EFO_0000714, HP_0100806
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	1.51e-04	3	210	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	1.51e-04	3	210	2	DOID:8545 (implicated_via_orthology)
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	3.00e-04	4	210	2	cv:CN293514
Disease	Gingival bleeding	ASIC2 NRXN1	3.00e-04	4	210	2	HP_0000225
Disease	JT interval	LRCH1 NAA35 PXDN KCNJ4 RAB29 CUL4A CREBBP SLC4A3	4.25e-04	248	210	8	EFO_0007885
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	4.97e-04	5	210	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE2 SYNE1	4.97e-04	5	210	2	C0410190
Disease	atopy	ADGRV1 PAK5	4.97e-04	5	210	2	EFO_0002686
Disease	interleukin-10 receptor subunit beta measurement	IL10RB ITSN1	4.97e-04	5	210	2	EFO_0020489
Disease	alcohol use disorder (implicated_via_orthology)	PDPK1 SREBF2 RYR1 RYR2 GLP1R CREBBP PRKCH	5.17e-04	195	210	7	DOID:1574 (implicated_via_orthology)
Disease	level of Sphingomyelin (d40:2) in blood serum	GC SYNE2 ANKRD17	5.67e-04	23	210	3	OBA_2045181
Disease	Adenocarcinoma of lung (disorder)	TRPM6 KCNJ4 FGFR3 PAK5 CREBBP ENO1 PSKH2	7.15e-04	206	210	7	C0152013
Disease	Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	7.42e-04	6	210	2	cv:C0410189
Disease	primary progressive multiple sclerosis (is_marker_for)	BCHE GC	7.42e-04	6	210	2	DOID:0050784 (is_marker_for)
Disease	BAG family molecular chaperone regulator 4 measurement	BCHE SLCO1B1	7.42e-04	6	210	2	EFO_0802303
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE2 SYNE1	7.42e-04	6	210	2	C0410189
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	1.03e-03	7	210	2	C0751337
Disease	level of Sphingomyelin (d38:1) in blood serum	GC SYNE2 ANKRD17	1.25e-03	30	210	3	OBA_2045180
Disease	vitamin D measurement, vitamin D dietary intake measurement	CYP24A1 GC	1.37e-03	8	210	2	EFO_0004631, EFO_0008539
Disease	QT interval	ASIC2 NOL6 LRCH1 PXDN KCNJ4 KCNQ3 CUL4A ITSN1 CREBBP SLC4A3 SLC16A4	1.64e-03	534	210	11	EFO_0004682
Disease	anemia (phenotype), response to ribavirin	CYP24A1 DNAH17	1.76e-03	9	210	2	EFO_0004272, GO_1901559
Disease	interferon alpha/beta receptor 1 measurement	IL10RB ITSN1	1.76e-03	9	210	2	EFO_0021850
Disease	Malignant neoplasm of breast	ABCA3 PDPK1 CYP24A1 SREBF2 BCHE DAP3 MIA2 SYNE2 SYNE1 CPT1A SLCO1B1 PRKAA2 ENO1 TNS1 GEN1 TOP1 DOP1A	1.85e-03	1074	210	17	C0006142
Disease	visceral heterotaxy (implicated_via_orthology)	OSBPL1A DNAH5 MEGF8	2.31e-03	37	210	3	DOID:0050545 (implicated_via_orthology)
Disease	response to angiotensin-converting enzyme inhibitor	ASIC2 ELAC2 NRXN1 PIP5K1B	2.36e-03	78	210	4	EFO_0005325
Disease	C-reactive protein measurement	CFAP251 ZZEF1 JMY PXDN NR1H4 CUL4A FBLN7 ANK3 DDX52 ANXA4 NEK7 HIF3A SLC9A4 RP1L1 DNAH17 AACS CEACAM20 TOP1	2.58e-03	1206	210	18	EFO_0004458
Disease	hyperhomocysteinemia (implicated_via_orthology)	BCHE CBS	2.66e-03	11	210	2	DOID:9279 (implicated_via_orthology)
Disease	Pancreatic Ductal Adenocarcinoma	ABCD2 ABCB5	2.66e-03	11	210	2	C1335302
Disease	PR interval	OMA1 MYCBP2 ASIC2 SPTBN1 MYOZ2 LRCH1 RYR2 SYNE2 ABCB5 SUN1	3.04e-03	495	210	10	EFO_0004462
Disease	Drug toxicity	BCHE GC SLCO1B1 TOP1	3.09e-03	84	210	4	C0013221
Disease	Adverse reaction to drug	BCHE GC SLCO1B1 TOP1	3.09e-03	84	210	4	C0041755
Disease	platelet component distribution width	CAPN12 ZZEF1 LRCH1 JMY MIA2 ANKDD1B PIP5K1B CUL4A SYNE1 RNPEPL1 TEX11 KCTD17 OTP	3.10e-03	755	210	13	EFO_0007984
Disease	Carcinoma, Transitional Cell	FGFR3 CREBBP STAG2	3.10e-03	41	210	3	C0007138
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE2 SYNE1	3.17e-03	12	210	2	DOID:11726 (implicated_via_orthology)
Disease	arachidonoylcarnitine (C20:4) measurement	CPT1A SLCO1B1	3.17e-03	12	210	2	EFO_0800544
Disease	Autism Spectrum Disorders	LRRTM3 RYR2 NRXN1 LRRN3	3.22e-03	85	210	4	C1510586
Disease	fibroblast growth factor 23 measurement	CYP24A1 PIP5K1B NSD1	3.56e-03	43	210	3	EFO_0009381
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN12 NIPAL4 SEC23IP	3.56e-03	43	210	3	DOID:2476 (implicated_via_orthology)
Disease	Autosomal Dominant Myotubular Myopathy	RYR1 MTMR14	3.73e-03	13	210	2	C3661489
Disease	Centronuclear myopathy	RYR1 MTMR14	3.73e-03	13	210	2	C0175709
Disease	X-linked centronuclear myopathy	RYR1 MTMR14	3.73e-03	13	210	2	C0410203
Disease	dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement	CPT1A SLCO1B1	3.73e-03	13	210	2	EFO_0800547
Disease	ximenoylcarnitine (C26:1) measurement	CPT1A IGHMBP2	3.73e-03	13	210	2	EFO_0800543
Disease	cerotoylcarnitine (C26) measurement	CPT1A IGHMBP2	3.73e-03	13	210	2	EFO_0800542
Disease	Myopathy, Centronuclear, 1	RYR1 MTMR14	3.73e-03	13	210	2	C4551952
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	KCNQ3 FARS2	3.73e-03	13	210	2	DOID:0112202 (implicated_via_orthology)
Disease	Congenital Structural Myopathy	RYR1 MTMR14	3.73e-03	13	210	2	C0752282
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	SYNE2 ANKDD1B CPT1A TMED4 CEACAM20	3.77e-03	144	210	5	EFO_0004611, EFO_0020943
Disease	Multiple Sclerosis	BCHE GC IL7	4.05e-03	45	210	3	C0026769
Disease	Multiple Sclerosis, Acute Fulminating	BCHE GC IL7	4.05e-03	45	210	3	C0751324
Disease	obesity (biomarker_via_orthology)	SREBF2 GLP1R NR1H4 CPT1A AACS	4.11e-03	147	210	5	DOID:9970 (biomarker_via_orthology)
Disease	Myopathy, Centronuclear, Autosomal Dominant	RYR1 MTMR14	4.34e-03	14	210	2	C1834558
Disease	Tubular Aggregate Myopathy	RYR1 MTMR14	4.34e-03	14	210	2	C0410207
Disease	Adenocarcinoma of large intestine	GRK2 FGFR3 PAK5 PRKCH	4.97e-03	96	210	4	C1319315
Disease	Down syndrome (implicated_via_orthology)	CBS DOP1A	4.98e-03	15	210	2	DOID:14250 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	FGFR3 STAG2	4.98e-03	15	210	2	C0496930
Disease	gamma-glutamylphenylalanine measurement	LRRTM3 ARHGEF2	4.98e-03	15	210	2	EFO_0021142
Disease	Benign neoplasm of bladder	FGFR3 STAG2	4.98e-03	15	210	2	C0154017
Disease	Carcinoma in situ of bladder	FGFR3 STAG2	4.98e-03	15	210	2	C0154091
Disease	Autosomal Recessive Centronuclear Myopathy	RYR1 MTMR14	4.98e-03	15	210	2	C3645536
Disease	blood urea nitrogen measurement	PDE1A CYP24A1 MYOZ2 ADGRV1 PIK3CG PIP5K1B TNPO1 PLCD4 AP5B1	5.31e-03	452	210	9	EFO_0004741
Disease	diastolic blood pressure, body mass index	GLP1R EFHC2	5.66e-03	16	210	2	EFO_0004340, EFO_0006336
Disease	filaggrin gene expression measurement	CARD14 SLC35F4	5.66e-03	16	210	2	EFO_0020899
Disease	alpha fetoprotein measurement	SETX SLCO1B1 ANKRD17 GEN1	5.74e-03	100	210	4	EFO_0010583
Disease	episodic memory	TRPM6 TNPO1 TPST2	6.08e-03	52	210	3	EFO_0004333
Disease	sphingomyelin 14:0 measurement	SYNE2 PAK5	6.39e-03	17	210	2	EFO_0010390
Disease	hyperglycemia (implicated_via_orthology)	GRK2 GLP1R	6.39e-03	17	210	2	DOID:4195 (implicated_via_orthology)
Disease	ulcerative colitis (is_implicated_in)	CYP24A1 GC	6.39e-03	17	210	2	DOID:8577 (is_implicated_in)
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	IL10RB TLR9	6.39e-03	17	210	2	DOID:8677 (biomarker_via_orthology)
Disease	Diffuse Large B-Cell Lymphoma	PDPK1 PIK3CG CREBBP	7.10e-03	55	210	3	C0079744

Protein segments in the cluster

Peptide	Gene	Start	Entry
MDVHDLFRRLGAGAK	DDX52	1	Q9Y2R4
SMFDLIGLENKITRH	EP400	1411	Q96L91
ADKAEMRASRILHGL	ABCF2	201	Q9UG63
LGRSIATLMSDKLFH	SLC4A3	571	P48751
FLLLCMLIGKSHTED	BCHE	16	P06276
LEKLDSRDGKFIHRM	CWC25	376	Q9NXE8
HVVKVADFGLSRLMT	ABL2	421	P42684
RLNFKVEEGMHLLIT	ABCD2	496	Q9UBJ2
HAAKSLAMIVGIFAL	ADORA2B	231	P29275
ELLGLHHFMDSFKVV	AADAC	51	P22760
ERVILFLKMASGHAF	AACS	581	Q86V21
GEILTMRLRHLAFKA	ABCB5	761	Q2M3G0
LLDAHMNAKIADFGL	PRKAA2	146	P54646
ELLREKVGLFAEMTH	ARHGEF2	606	Q92974
LSIVFHERMQLSKDG	CEACAM20	106	Q6UY09
EEILMKRNHLGAFLI	GRAPL	71	Q8TC17
EEILMKRNHLGAFLI	GRAP	71	Q13588
LHTFARDLGEKMALE	AGRN	1651	O00468
MEFFLPTIHKRASLG	ADGRV1	1831	Q8WXG9
ELLFEAGEMRKSLHV	ADGRV1	4321	Q8WXG9
SLALRDVGMIFHTIE	ARHGEF11	1416	O15085
EQAYLRHLGMLEELK	CCDC96	281	Q2M329
MDGRDAFLTLARDKH	CREBBP	1661	Q92793
GRHLKEAMTDIITLF	CPT1A	751	P50416
AFTRDGHMADTLLLL	ABCA3	1171	Q99758
NLLARHRISVMGKDF	DOP1A	1421	Q5JWR5
TLVFNKLIMGHLDLA	ADCY10	1301	Q96PN6
AEIDMLDIRAHFKRL	ANXA4	276	P09525
FMLAENISHGLLLRK	AMPD2	701	Q01433
KGHLEMVRFLLEAGA	ANKRD17	411	O75179
NLERLEMLGDSFLKH	DICER1	1311	Q9UPY3
LLKSLGIHDLMHFDF	DHX16	766	O60231
EDALHGALKMLRQLF	BBS10	411	Q8TAM1
KMDFTAARLQRGHLL	DNAJC3	101	Q13217
LLHTLGFDSVRKRMS	ATP10A	736	O60312
LLAFLKLIDEGSHMV	ABHD8	386	Q96I13
KLSFILDLMNGGDLH	GRK2	266	P25098
FLRLLVTKGEHMTEE	CFAP251	1071	Q8TBY9
FSMLEFLHRVGHDLK	ASIC2	151	Q16515
GFIDKEDLHDMLASL	MYL12A	46	P19105
HREGMLFISKLDGRL	NSD1	2186	Q96L73
MGSRDHLFKVLVVGD	RAB29	1	O14966
GHMLLSLSRGKQDFL	RGPD5	356	Q99666
GHMLLSLSRGKQDFL	RGPD8	356	O14715
IALLKGSAVEAMFLR	NR1H4	331	Q96RI1
VGIADALIHMTLAFR	OR5W2	151	Q8NH69
AGIIRMLEFGSHLDL	KCNJ4	411	P48050
LHKVSSVLRGFLDLM	PAK5	666	Q9P286
YAIIGLELFLGRMHK	CACNA1F	251	O60840
FAEGIRHMKSRLAAL	FBLN7	51	Q53RD9
LGHLLRILFKNDDFM	DCAF1	71	Q9Y4B6
FIDKLLILEAGHRMS	PSKH2	296	Q96QS6
RASEHMELALGVDLK	MAGEB18	151	Q96M61
ADADIQLKGHMARFL	LAMA3	1016	Q16787
MDEVLASLKRGSFHL	JMY	891	Q8N9B5
LAESDEGKLHVLRVM	NCBP1	576	Q09161
KDLRMHLSNTLLDGE	RNGTT	331	O60942
ASLLGDMHFRSLRTK	FXR2	191	P51116
AREVMILITGAHKAF	GNPDA1	196	P46926
FSMKGLHLDATLDAV	MSS51	191	Q4VC12
GHMLVDRLSKGEEIF	MTMR14	376	Q8NCE2
MDEHARGTLRFIKLF	GLP1R	371	P43220
LGRVMLLHSKIFTDA	KCNN1	241	Q92952
SAGHLDMLSRIKYLQ	KCNQ3	551	O43525
ALGLHVAEMSEKELF	DUOX2	741	Q9NRD8
LDFLMEALIISKFRH	LTK	556	P29376
REPVLKAMFLADTHL	MPPE1	66	Q53F39
KAMFLADTHLLGEFL	MPPE1	71	Q53F39
LPHSSGRDALKMFLR	EFHC2	266	Q5JST6
FMVSILFSKLGDLLH	PCNX2	1271	A6NKB5
MAFGSLLKEGIHVRL	OGDHL	646	Q9ULD0
LLMGFSDERKLQILH	OR14J1	11	Q9UGF5
GIDRAKTMSLILHAA	PDE1A	351	P54750
LELADAGDLSRMIKH	NEK7	111	Q8TDX7
SHRGEKLLLFMGIID	PIP5K1B	336	O14986
VLNHVLRDIELFMGK	EPS8L3	241	Q8TE67
SGVDMNAARLLFHKL	HERC4	456	Q5GLZ8
MDALKDLLRHTGRLS	PRAMEF18	391	Q5VWM3
AKLRPSADELLRHMF	MAP3K2	601	Q9Y2U5
MLLDSRADDGFHLLL	NOL6	446	Q9H6R4
DAREMSKTFIIGELH	CYB5A	71	P00167
IEASSGKMLLHLFSD	MEGF8	111	Q7Z7M0
EMRLKVSLHEDLGAA	LRCH1	591	Q9Y2L9
RMLGLDGSLVFLEHV	MARCHF6	276	O60337
KRRLLMVPDGFISHF	MIGA2	481	Q7L4E1
MLTERGHKLSVLAVD	MMAA	166	Q8IVH4
LTLLHAMLALKAAFG	AP5B1	321	Q2VPB7
IKVDFFAIEMLDGHL	NRXN1	536	Q9ULB1
VKLLASVRALDHAMS	PAXBP1	886	Q9Y5B6
EKMEFRTASIRLFGH	MROH1	1461	Q8NDA8
HRAAFTGRKELVMLL	OSBPL1A	86	Q9BXW6
GILSFIEDVAHRMLA	OSGEP	206	Q9NPF4
FLRHGKLVLDKDMAE	KCTD17	91	Q8N5Z5
RIAHMLEGSEKNLHF	PLCXD1	106	Q9NUJ7
MSILKIHAREIFDSR	ENO1	1	P06733
HRASLEGHMEILEKL	ANKRD2	186	Q9GZV1
MVLLHVKRGDESQFL	CFAP298	1	P57076
SMGLFSALRHALAKE	CAPN12	221	Q6ZSI9
DFSGLTKLELLMLHS	IGSF10	76	Q6WRI0
LIMGTHRDLEAFKRL	BRME1	621	Q0VDD7
SAMRAGHLLDLLKTR	CARD14	66	Q9BXL6
ILDEMSHKLRLGAIR	GNPAT	106	O15228
IFRMKLGSFESVHLG	CYP24A1	96	Q07973
MAEGFLEARLLARKF	DNAH17	1986	Q9UFH2
SLEDLVSLFMIHKDG	DNAH3	456	Q8TD57
ILAGSFETAMRLLHD	COPA	931	P53621
SDLVSDILIHGMKAR	DIS3L	271	Q8TF46
RTLDKIMILFRFIHG	CUL4A	431	Q13619
DGKLTAEEFILAMHL	ITSN1	271	Q15811
MLFGSDRMELLAHLL	GSTK1	196	Q9Y2Q3
DLMELKAEHVRLSGS	CEP250	201	Q9BV73
LGRLSHILEMDHFAL	CBS	496	P35520
LFVHASSRGFLDKML	CATIP	86	Q7Z7H3
HFGSMRGKERELIVL	ANK3	1066	Q12955
ITMAHLLAAREDLSK	FAM98B	266	Q52LJ0
DGKTELSLMRFSLAH	ATG9B	701	Q674R7
EVLADSLHMRFLAPK	IL10RB	121	Q08334
FLKMNSTGDFDLHLL	IL7	91	P13232
AREVMILITGAHKAF	GNPDA2	196	Q8TDQ7
REILFLTMAALGKDH	DENND4B	1431	O75064
LVLLTHYDMIERKLG	GEN1	376	Q17RS7
MKIADFGLARDVHNL	FGFR3	631	P22607
DFLGMLVHTRSLLKE	FIBIN	161	Q8TAL6
EMAAGRLLELHTYLK	DNAH2	1041	Q9P225
IDASMFARKHESPLL	RUBCN	186	Q92622
LSLLGDITIDHHKIM	S100A7L2	76	Q5SY68
AAHLLDIAMGVKTLR	RYR1	4811	P21817
AHLLDIAMGFKTLRT	RYR2	4741	Q92736
AGHSLLMDARDLVLK	METTL17	301	Q9H7H0
HILSMARLAKDVLAE	CPNE8	516	Q86YQ8
MAAYKLVLIRHGESA	PGAM1	1	P18669
FLDHIRKVMLVIDAA	NGB	61	Q9NPG2
MAKVLLEFEVLFHRA	DNAH5	666	Q8TE73
KRMLSFQGLAELAHR	OGT	16	O15294
AKAELATFLRGVLLM	OR52N5	151	Q8NH56
MLSHADLLDARLGMK	OTP	1	Q5XKR4
MAKFGVHRILLLAIS	MIA2	1	Q96PC5
LFAHEFKVLEGMSLV	FREM3	1196	P0C091
MLLFNDLVLHGDVKE	FER1L6	876	Q2WGJ9
HRLDRLTSGVLMFAK	RPUSD2	271	Q8IZ73
ELKRQSSLGMFHLLV	DAP3	246	P51398
SFLLDHEKEMILGVL	SYTL5	11	Q8TDW5
AFRLDALHRQMKLLG	RNPEPL1	401	Q9HAU8
LKRMLFESLHHGLDD	TRMT1L	541	Q7Z2T5
GVMALVFAIKAEERH	TMEM265	46	A0A087WTH1
DSGKLRHVLSMDGFL	PLCD4	256	Q9BRC7
HLMGVLREFFTKLGI	FARSA	386	Q9Y285
GLESHMILTETLFRK	SYNE1	6636	Q8NF91
DFGVRLESLKGLIMH	SYNE2	5501	Q8WXH0
LHGHSSLKEALRMAL	LARS2	321	Q15031
FAGMIRLKELHLEHN	LRRTM3	201	Q86VH5
RRGDFSNMLHLKELG	LRRN3	276	Q9H3W5
LKHDRAFLLSMANRG	NKTR	101	P30414
SFLTHEDIMPRGKFL	SAMD9	526	Q5K651
MDGLKDLLRHTGRLS	PRAMEF19	391	Q5SWL8
RDVMSRLDHPFFVKL	PDPK1	131	O15530
LGRGAFLSRHSLDMK	HIF3A	236	Q9Y2N7
EELHIRLMDHLKAGI	SLC9A4	491	Q6AI14
KYSLFILGHLRTLME	SETX	2416	Q7Z333
EREMTFKHAALLHLL	SHOC1	651	Q5VXU9
GLEFAHMALALSITL	SH3TC1	1171	Q8TE82
ADLKEHMVGIIFSRS	MYCBP2	3946	O75592
HLELKESLSRMGSDL	SEC23IP	856	Q9Y6Y8
DVRLIGEKLFHGVSM	IL22	71	Q9GZX6
KALLHRDTMLAAAAV	NDUFAF5	271	Q5TEU4
MDELLLDLFHKLTSG	SLC35F4	1	A4IF30
HAAEKAGMVHLLDFL	OMA1	336	Q96E52
ELKSLALGFHSMVIR	SLCO1B1	566	Q9Y6L6
LLSKHRAFEDEMSGR	SPTBN1	676	Q01082
LMRARKHGLVDFEGE	ABRA	351	Q8N0Z2
FLLAAERGHVEMIEK	ANKDD1B	206	A6NHY2
HSGLLLSRVMKERDA	CFAP210	156	Q0VFZ6
KMDHRSDLVFLADLR	CHST14	181	Q8NCH0
FSKADHFRLGSVLVM	CNOT11	96	Q9UKZ1
HGLSLFLRGSLEEKM	CLXN	91	Q9HAE3
IFKHGDDLRQDMLIL	PIK3CG	831	P48736
VSVEDMAHAARKLGL	URGCP	446	Q8TCY9
VAGLREKIHHLDDML	TUFT1	281	Q9NNX1
SKFLLMVRDGRASVH	TPST2	176	O60704
EEHLKLAGMADGLFL	ZAP70	21	P43403
VFLHLGRTMKEDLEA	TNFAIP2	216	Q03169
DVMLDTFRLLVSVGH	ZNF135	41	P52742
FLHVRKATRAMGLLN	TMEM175	331	Q9BSA9
LLGIRKFMLERNHTS	ZNF826P	26	Q6ZT77
LAFTHKHLADEGMLR	TRPM6	326	Q9BX84
EALVRMGKDATLLIH	ELAC2	671	Q9BQ52
HLVARAKTLGIDIMD	SLC16A4	321	O15374
GELLHDKLFGLFEAM	NAA35	46	Q5VZE5
LSVEMKVRFHLVGED	RP1L1	321	Q8IWN7
SLLLRMEEVGRKLHS	TBC1D8B	1021	Q0IIM8
LKELDMHGIFFRSLD	TLR9	366	Q9NR96
TREAIAMLHKDGIEF	STAG2	966	Q8N3U4
HKAALAGLSLSLMER	IGHMBP2	411	P38935
VAEKLIRLAGFDEHM	TOMT	171	Q8WZ04
CHLMKDLARTLLTVG	SYCP2L	211	Q5T4T6
KVFLHEATVRLMAGA	SREBF2	1031	Q12772
KGDMTHELVRHFLIE	TNS1	1516	Q9HBL0
GTFNHLESMKRLRLD	PXDN	176	Q92626
MKRVLVLLLAVAFGH	GC	1	P02774
SVKELRDMGITLHLL	SCFD1	61	Q8WVM8
IAKLLMDHERESVGF	TEX11	341	Q8IYF3
HLREGMTLLKTEFAL	SERPINE3	21	A8MV23
KMRIEVGLDLLHFAL	NME9	51	Q86XW9
VLVFMGCLLKDHDTL	UBQLNL	71	Q8IYU4
KLEQFLADHLLLMGA	TSPAN11	211	A1L157
MFRLEHGEADRSTLK	YJU2B	146	P13994
KDFMIVALDLLSGLA	TNPO1	646	Q92973
ILGVFMLHAFKDLDI	NIPAL4	336	Q0D2K0
MALFAGGKLRVHLDI	TMED4	121	Q7Z7H5
FLSKARETFLMAHDG	ZSWIM6	1171	Q9HCJ5
ELHERAMKFLLPFST	ZMYM6	1266	O95789
KEGLDIHSSMILRFL	ZZEF1	176	O43149
LFGQLLRLKMFREDH	TMEM117	91	Q9H0C3
LVEIEGVSKMAFRHL	ZNF131	71	P52739
HEVRMSHLEDILGKL	SUN1	431	O94901
TLTRLMAHLFGDELE	FARS2	246	O95363
ARLEKFMHFGAVLAL	WDR87	456	Q6ZQQ6
HLQDLMEGLTAKVFR	TOP1	576	P11387
MKHGDLHAFLLASRI	TYRO3	606	Q06418
MFLKDLRGHVELSEA	ZC3HAV1L	21	Q96H79
AEIISALMFLHDKGI	PRKCH	461	P24723
KHALRVLDMTGLLDD	LRRC14	111	Q15048
MDVFKILAAILHLGN	MYO5C	321	Q9NQX4
ELSHLSNRGARLFKM	MYOZ2	46	Q9NPC6
ALHLSKGMSIFLDIL	NECAB1	21	Q8N987